Evidence for higher success rates and successful treatment earlier in Graves' disease with higher radioactive iodine doses
S Sztal-Mazer, VY Nakatani, LG Bortolini… - Thyroid, 2012 - liebertpub.com
Background: Graves' disease is commonly treated with curative intent using radioactive
iodine (RAI). While higher doses have been shown to increase success rates, more …
iodine (RAI). While higher doses have been shown to increase success rates, more …
Predictive factors of failure in a fixed 15 mCi 131I-iodide therapy for Graves' disease
A Moura-Neto, C Mosci, AO Santos… - Clinical nuclear …, 2012 - journals.lww.com
Purpose To investigate the factors influencing the success rate in a fixed, 15 mCi approach
for treatment of Graves' hyperthyroidism. Material and Methods The thyroid function outcome …
for treatment of Graves' hyperthyroidism. Material and Methods The thyroid function outcome …
Predictive factors for the outcomes of Graves' disease patients with radioactive iodine (131I) treatment
YZ Xing, K Zhang, G Jin - Bioscience reports, 2020 - portlandpress.com
Although radioactive iodine (131I) treatment (RIT) is recommended as the preferred option
for patients with Graves' disease (GD), the predictive factors for its clinical outcomes are still …
for patients with Graves' disease (GD), the predictive factors for its clinical outcomes are still …
Predictive factors of outcomes in personalized radioactive iodine (131I) treatment for Graves' disease
M Liu, D Jing, J Hu, S Yin - The American Journal of the Medical Sciences, 2014 - Elsevier
Background Graves' disease (GD) is the most common cause of hyperthyroidism in iodine-
sufficient areas. Radioactive iodine 131 I treatment (RIT), as the 1st therapeutic option, is …
sufficient areas. Radioactive iodine 131 I treatment (RIT), as the 1st therapeutic option, is …
Response rate and factors affecting the outcome of a fixed dose of RAI-131 therapy in Graves' disease: a 10-year Egyptian experience
M Abd El-Kareem, WA Derwish… - Nuclear medicine …, 2014 - journals.lww.com
The aim of this study was to evaluate response and compare the success rate of two
different doses of iodine-131 (131 I) therapy in the treatment of Graves' disease and …
different doses of iodine-131 (131 I) therapy in the treatment of Graves' disease and …
Evaluation of 99Tcm-DTPA orbit SPECT/CT combined with thyroid function test in the treatment of radioactive iodine I-131 in patients with thyroid-associated …
L Su, P Mi, W Niu, T Zhou, W Yang… - Journal of Medical …, 2024 - aseestant.ceon.rs
Objective: Thyroid-associated ophthalmopathy (TAO) is an autoimmune response to
inflammation of the thyroid and orbital tissue. This research evaluated the efficacy of 99Tcm …
inflammation of the thyroid and orbital tissue. This research evaluated the efficacy of 99Tcm …
Identification of patients with Graves' disease who benefit from high-dose radioactive iodine therapy
S Watanabe, S Okamoto, K Akikawa… - Annals of nuclear …, 2022 - Springer
Objective Radioactive iodine (RAI) therapy is a useful treatment for Graves' disease (GD).
Most RAI sessions administer≤ 500 MBq of iodine (I)-131. Sometimes patients require …
Most RAI sessions administer≤ 500 MBq of iodine (I)-131. Sometimes patients require …
14 years Radioiodine therapy in management of thyrotoxicosis (single institutional study)
MAE Husseini, MA Abougabal - Egyptian Journal Nuclear Medicine, 2022 - journals.ekb.eg
Objective: Present our 14-year experience in Radioactive iodine-131 (131RAI) therapy in
Gravess disease (GD) and toxic adenoma (TA). Methods: 525 patients were included, 445 …
Gravess disease (GD) and toxic adenoma (TA). Methods: 525 patients were included, 445 …